Patients with chronic hepatitis C receiving treatment with direct acting antivirals: How is this population changing?

Direct acting antiviral agents (DAAs) have revolutionized the landscape of chronic hepatitis C (CHC) enabling treatment of all those infected. It remains to be determined how the characteristics of those receiving treatment are changing.

Source: Digestive and Liver Disease - July 26, 2020 Category: Gastroenterology Authors: Andrea Lombardi, Marta Colaneri, Kesav Aditya Vijayagopal, Margherita Sambo, Patrizia Legnazzi, Paolo Sacchi, Valentina Zuccaro, Laura Maiocchi, Renato Maserati, Roberto Gulminetti, Layla Pagnucco, Stefano Novati, Domenico Zanaboni, Giuseppe Michelone, Se Tags: Liver, Pancreas and Biliary Tract Source Type: research